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EBNA1Epstein–Barr virus (EBV) nuclear antigen 1 (EBNA1) is essential for maintenance of the episome and estab-
lishment of latency. In this study, we observed that heat treatment effectively induced EBNA1 transcription
in EBV-transformed B95-8 and human LCL cell lines. Although Cp is considered as the sole promoter used
for the expression of EBNA1 transcripts in the lymphoblastoid cell lines, the RT-PCR results showed that
the EBNA1 transcripts induced by heat treatment arise from Qp-initiated transcripts. Using bioinformatics,
a high afﬁnity and functional heat shock factor 1 (HSF1)-binding element within the −17/+4 oligonucleo-
tide of the Qp was found, and was determined by electrophoretic mobility shift assay and chromatin immu-
noprecipitation assay. Moreover, heat shock and exogenous HSF1 expression induced Qp activity in reporter
assays. Further, RNA interference-mediated HSF1 gene silencing attenuated heat-induced EBNA1 expression
in B95-8 cells. These results provide evidence that EBNA1 is a new target for the transcription factor HSF1.Oncology in South China, Cancer
st, 510060 Guangzhou, China.
ied@mail.sysu.edu.cn (D. Xie).
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Epstein–Barr virus (EBV) is a ubiquitous human gamma herpesvi-
rus that is associated with infectious mononucleosis and the human
malignancies Burkitt's lymphoma (BL), nasopharyngeal carcinoma
(NPC), Hodgkin's disease (HD), and lymphoproliferative disease aris-
ing in immunosuppressed patients (Tao et al., 2006). The virus is ca-
pable of adopting three latency programs, denoted latency I, II and III,
that is controlled by distinct usage of three promoters (Kerr et al.,
1992). In type III latency seen in lymphoblastoid cell lines and in lym-
phomas of the immunocompromised, all six nuclear antigens
(EBNA1–6) are expressed under the transcriptional control of either
the C or W promoter. In types I and II latency, Cp and Wp are inactive
as a result of methylation (Schaefer et al., 1997) and the expression of
nuclear antigens is restricted to EBNA1 driven by the Qp, a promoter
in the BamHI Q fragment of the viral genome (Nonkwelo et al., 1996;
Schaefer et al., 1995a; Schaefer et al., 1995b). The viral protein ex-
pression in EBV-associated tumors is restricted to either EBNA1
(type I latency), as in BL, or to EBNA1 plus the latent membrane pro-
tein (LMP) 1 (type II latency) in NPC, EBV-positive HD and T-cell lym-
phoma (Deacon et al., 1993; Pallesen et al., 1991; Young et al., 1988).
Thus, EBNA1 is the only EBV protein expressed in all known states ofEBV latency. Besides, EBNA1mRNA could also be transcribed from the
BamHI-F promoter during the viral lytic cycle (Lear et al., 1992).
The heat shock response is highly conserved and constitutes a uni-
versal mechanism of protection against adverse environmental con-
ditions. It is known that various organisms and cell cultures, from
bacteria to humans, respond to a mild heat shock. Heat shock factor
(HSF) 1 is the master regulator that mediates the activation of the
heat shock response in eukaryotes (Wu, 1995). Under normal condi-
tions, HSF1 is found predominantly as inactive monomers. When ex-
posed to stress, HSF1 is activated through a monomer-to-trimer
transition, nuclear accumulation and subsequent binding to heat
shock elements (HSEs) present in heat shock gene promoters and in-
crease the transcriptional rate of target genes (Zuo et al., 1994). EBV
genes expression could also be affected by stress stimuli. An early re-
port showed that heat shock induced abortive infection with expres-
sion of early antigens (EA) in the EBV non-producer Raji cell line and
led to an increased percentage of EBV viral capsid antigen-positive
cells in the spontaneously producing cell line P3HR1 (Zerbini et al.,
1985). Our previous study revealed that hypoxia treatment increased
the expression of the EBV immediate-early protein Zta and EBV DNA
copy numbers in B95-8 cells (Jiang et al., 2006). However, the effect of
heat shock on EBV latent gene expression has not been investigated.
In the present study, we investigated the changes in expression of
EBV gene transcripts after heat shock treatment and revealed that hy-
perthermia induced EBNA1 expression transcribed from Qp via a
HSF1-dependent mechanism in B95-8 cells. We ﬁrst described the
presence of a potential HSE located between −17 and +4 to the
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quence was demonstrated by electrophoretic mobility shift assay
(EMSA) and chromatin immunoprecipitation assay (ChIP). Furthermore,
HSF1 knockdown by RNA interference markedly suppressed the basal
and heat-induced expression of the EBNA1 gene. These data suggest
that HSF1 plays a role in the regulation of EBNA1 expression.Results
Heat shock affects EBNA1 gene transcription in cell lines
To investigate the impact of the heat shock stress on EBV genes ex-
pression, B95-8 and human LCL cell lines were heat-treated and
allowed to recover at 37 °C for different time periods as indicated,
or were not heat-treated. The cell extract was examined for the pres-
ence of viral RNA transcripts by RT-PCR. The primer pairs were
designed in order to characterize the promoter usage of the viral tran-
scripts. Cp- and Wp-initiated transcripts have BamHI-C1/C2/W1/W2-
and BamHI-W0/W1/W2-spliced structures, respectively. Therefore,
the primer pair C1/C2 and W2 was used for Cp-initiated transcripts,
and the primer pair W0/W1 and W2 was used for Wp-initiated tran-
scripts. It was shown that Cp-initiated transcripts could readily be
detected, whereas the Wp-initiated RNA was undetectable (Fig. 1).
The results were consistent with the previous study that Cp, but not
Wp is active in B95-8 cell line (Schlager et al., 1996).
To discern the promoter usage of EBNA1 transcripts, the various
primer combinations were designed to detect mRNA molecules initi-
ated at: Cp andWp (Y3/K), Fp and Qp (Q/K), Fp only (F/K). As showed
in Fig. 1A, the Y3/K and F/K-spliced EBNA1 transcripts, expressed
from Cp/Wp and Fp respectively, could be detected from unheated
and heated B95-8 cells, and the expression level had no changes
after heat shock treatment compared with the cells maintained at
normal growth temperature. Conversely, the expression of transcripts
with the BamHI Q/K splice structure, expressed from Fp or Qp, was
very weak in unheated B95-8 cells but signiﬁcantly elevated in
heat-treated cells. Quantiﬁcation of mRNA using real-time RT-PCR
(Fig. 2C) shown that heat shock treatment increased Q/K-spliced
EBNA1 mRNA expression by 2.81-fold (0.42±0.031 vs. 1.18±
0.057) after 48 h recovery at 37 °C compared with untreated cells. In-
creased Q/K-spliced transcripts levels also correlated with increased
levels of EBNA1 protein as demonstrated by Western blotting
(Fig. 2B). Although the Q primer might also detect Fp driven tran-
scripts, the constant level of Fp transcripts (F/K EBNA1) indicates
that increased signals found with the Q/K primers are truly derivedFig. 1. Heat shock treatment induced EBNA1 transcription from Q promoter. B95.8 (A) and EB
indicated recovery times. Then total RNA were extracted to detect the effect of the heat shoc
and W-promoter-generated mRNA (Wp) were ampliﬁed using forward primers in C1C2 an
were detected with different sense primers and a common antisense primer in K exon. EBN
(Y3/K EBNA1). EBNA1 with Q/K and F/K primers were used to detect Q-promoter and F-pro
amined by the indicated primers in Table 1. GAPDH mRNA was used as internal control. Thfrom Qp driven transcripts. Thus, this observation indicated that the
EBNA1 transcript initiated at Qp is upregulated by heat treatment.
PCR was also performed by using the primers speciﬁc for EBNA2
mRNA, another individual member of the Cp/Wp-initiated transcript
family, and BZLF1 mRNA, an immediately early transcript indicative
of the switch from latency into lytic cycle, as well as LMP1 mRNA.
The results showed that none of the transcripts were affected by
heat shock. To verify the results in B95-8, we reproduced the experi-
ments in human LCL cell line and obtained the similar results
(Fig. 1B). Our previous study showed that hypoxia treatment in-
creased the expression of the EBV immediate-early protein Zta and
EBV DNA copy numbers in B95-8 cells (Jiang et al., 2006). However,
the change in BZLF1 mRNA level was not detected by RT-PCR after
heat shock treatment in this study. It is possible that different regula-
tors and pathways are involved in the conditions under the two treat-
ments, heat and hypoxia, and exert different effects on EBV genes
expression. The BZLF1 expression might be induced by low pH or
low ATP other than HSF1. The increased EBV DNA copy numbers in
B95-8 cells treated with hypoxia in the previous study might be the
result of induced EBNA1 expression.
As the key factor involved in heat shock induced activation or re-
pression of speciﬁc genes, HSF1 could be expected to regulate EBNA1
expression. Therefore, we evaluated the effect of HSF1 inhibition on
EBNA1mRNA levels in heat-shocked B95-8 cells and found that trans-
fection of HSF1-speciﬁc siRNA eliminated the heat-mediated induc-
tion of EBNA1 mRNA expression (Fig. 2E). Compared with cells
transfected with HSF1-speciﬁc siRNA, heat shock treatment increased
EBNA1 mRNA expression of control cells (NC or MOCK) by 2.29 or
2.37-fold respectively (0.38±0.05 vs. 0.87±0.1 or 0.9±0.04) in the
real-time RT-PCR assay (Fig. 2F). These results revealed thatHSF1 is re-
quired in stress-induced EBNA1 expression in B95-8 cells. Surprisingly
HSF1 knockdown also reduced EBNA1 transcription in unheated control
cells. It is possible that there is low level of Qp-initiated EBNA1 tran-
scripts in unheated B95-8 cells since previous study has shown that
Qp transcripts can be detected in B95-8 cells and other cell lines in
group III latency (Tao et al., 1998).
HSF1 directly binds to HSE within the BamHI-Q promoter
The high afﬁnity binding sequence for HSF1 is comprised of a min-
imum of two nGAAn/nTTCn elements arranged as an inverted dyad
repeat. In order to understand how HSF1 is involved in heat-induced
EBNA1 expression, the promoter regions of EBV was analyzed for the
presence of HSE by TRANSFAC search (http://transfac.gbf.de/
TRANSFAC). No putative HSF1 binding site was found in the sequenceV-transformed human LCL cells (B) were heat shocked or not and incubated at 37 °C as
k treatment on EBV transcripts by RT-PCR. C-promoter-generated splice products (Cp)
d W0W1 exon respectively, and a common reverse primer in W2. EBNA1 transcripts
A1 transcripts derived from C- or W-promoter were detected by the common Y exon
moter generated products respectively. EBNA2, BZLF1, and LMP1 transcripts were ex-
ese ﬁgures were representative of three independent experiments.
Fig. 2. Hyperthermia upregulates EBNA1 mRNA and protein expression through HSF1-dependent mechanism in B95-8 cells. The mRNA and protein expression of EBNA1 gene was
determined by RT-PCR (A) and Western blot (B) in B95-8 cells. Total mRNA and whole cell extracts were obtained from untreated or heat-treated cells, followed by 12 h, 24 h and
48 h recovery at 37 °C. GAPDH was used to document equal amounts of cDNA and protein. (C) EBNA1 mRNA expression determined by real-time RT-PCR. Compared with untreated
cells, heat shock treatment increased EBNA1 mRNA expression by 2.81-fold (0.42±0.031 vs. 1.18±0.057). (D) The effect of small interfering RNA targeting HSF1 was veriﬁed by
Western blot. (E, F) The transcription level of EBNA1 was signiﬁcantly reduced in cells transfected with small interfering (si) RNA targeting HSF1 compared with that in negative
control siRNA (NC) and mock control (M) groups. After transfection with HSF1-speciﬁc siRNAs for 60 h, cells were heat-treated or not and allowed to recover for 20 h at 37 °C. The
mRNA of all samples were extracted and used to detect EBNA1 expression by RT-PCR (E) or real-time RT-PCR (F) with GAPDH as the internal control. Compared with cells trans-
fected with HSF1-speciﬁc siRNA, heat shock treatment increased EBNA1 mRNA expression of control cells (NC or MOCK) by 2.29 or 2.37-fold respectively (0.38±0.05 vs. 0.87±0.1
or 0.9±0.04). The result was expressed as the mean of three independent experiments±S.D. *, Pb0.05.
186 F.-W. Wang et al. / Virology 421 (2011) 184–191of Cp, Wp, Fp and LMP1 promoter based on DNA sequence analysis.
However, one putative HSF1 binding region, which is rich in pentanu-
cleotide nGGAn sequences, was found adjacent to the transcription
start site of the BamHI-Q promoter. We thus analyzed the sequences
and found 85% sequence identity between the putative HSE of Qp
(CGAAAACGAAAGTGCTTGAAA, −17 to +4 relative to the start site)
with the HSF1 binding region in the HSP90β promoter:
GGAAACTGCTGGAAA (−639 to −622) (Stephanou et al., 1999).
We further investigated and conﬁrmed that HSF1 bound to the
HSE present in the Q promoter region by EMSA analysis. The biotin
end-labeled−19/+5 oligonucleotide was utilized as a probe, and nu-
clear extracts from B95-8 cells were exposed to 43 °C for 1 h as a source
of HSF1. As shown in Fig. 3B, DNA-protein complexes were detected in
the extract of heat-treated B95-8 cells (lanes 2), and the binding was
completely blocked by the excessive unlabeled cold probes (lane 3), in-
dicating the speciﬁcity of the binding reaction. Furthermore, these
DNA–protein complexes could be speciﬁcally supershifted by an anti-
body against HSF1 (lane 5), but not by the non-speciﬁc antibody (lane
4). To further conﬁrm the speciﬁcity of DNA binding, mutant HSE (as
listed in Table 1) was biotin-labeled and used as a probe to test the nu-
clear extracts from heat treated B95-8 cells (Fig. 3C). We observed that
the wild-type HSE sequence formed a complex (lane 3) which was
supershifted by anti-HSF1 antibody (lane 5), while the mutant probe
failed to form a detectable speciﬁc DNA/protein complex (lane 4 and
6). These results suggested that a high afﬁnity HSE exists in the −17/
+4 region.
To substantiate the activity of the putative HSE region of the Qp in
vivo, we next performed a ChIP assay by using an HSF1 speciﬁc anti-
body. In the ChIP assay, normal rat IgG was used as antibody negative
control. To ensure that the DNA genome was sufﬁciently sheered by
sonication, the EBV LMP1 TR promoter (L1-TR) without potential
HSE sequences was used as a negative control. DNA associated with
the chromatin immunoprecipitated by these antibodies was then am-
pliﬁed by PCR with primers speciﬁc for the putative HSE region of theQp (Fig. 3D). As expected, no DNA fragments were detected when
normal IgG (lanes 1 and 2) or primers for L1-TR promoter (lanes 7
and 8) were used. By contrast, anti-HSF1 antibody speciﬁcally precip-
itated the Qp fragment in both unheated (lane 3) and heat-treated
cells (lane 4). In addition, the intensity of band 4 was increased by
2.15-fold compared with band 3 by using the Quantity One 1-D anal-
ysis software program (Bio-Rad), which indicates that heat treatment
increase the amount of immunoprecipitated DNA. These observa-
tions, together with our EMSA results, strongly supported that the
−17/+4 sequence of Qp contains an HSE with a binding afﬁnity for
HSF1.
We observed that EBNA1 suppression by HSF1 interference oc-
curred both in the heat treated and unheated cells. The binding of
HSF1 to the HSE from Qp was also observed under unstressed condi-
tions, although the signals were weaker than those in stressed cells in
the EMSA and ChIP assays. It is possible that a small amount of HSF1
trimers that exists in unstressed cells may bind to the Qp in vivo.
Heat shock and HSF1 overexpression enhance Qp activity
To further conﬁrm the capacity of HSF1 to regulate Qp activity, we
subcloned the Qp region (−219 bp to +58 bp), which contains the
putative HSE, into the pGL3 basic plasmid to drive the luciferase re-
porter gene expression. The resulting plasmid, Qp-luciferase was
transiently transfected into the HaCaT cell line, co-transfected with
HSF1 expressing plasmid or treated with heat shock. Expression of
constitutively active HSF1 strongly induced Qp, causing a 6.65±
0.79-fold increase over the empty vector, while the wild-type HSF1
increased Qp activity moderately (1.74±0.16-fold) (Fig. 4A). Heat
shock treatment induced Qp activity 2.0±0.21 times higher than
that of unheated group (Fig. 4B). To conﬁrm the binding site for
HSF1 in this sequence, the mutant construct was generated with the
same nucleotides substitutions in the mQp probe used in EMSA
assay by using the primers as listed in Table 1. After verifying the
Fig. 3. Identiﬁcation of HSF1-binding sequence in Qp. (A) HSF1 activation by heat shock at 43 °C for 1 h was conﬁrmed in B95-8 cell line by Western blot. The electrophoretic mo-
bility of activated HSF1 was slower than that of HSF1 from unstressed cells because of hyperphosphorylation induced by heat shock. (B, C) Double-strand oligonucleotide consensus
to the−19/+5 sequence of Qp was labeled with biotin. EMSA was carried out to detect its binding to the nuclear extract of the heat-treated B95-8 cells. The complex of HSF1/HSE is
indicated by arrow and the supershift band is indicated by asterisks. B, HSE/Qp bound to the nuclear extract from heat-treated B95-8 cells (lane 2). Nuclear extracts were incubated
with an anti-HSF1 supershifting antibody (lane 5), non-speciﬁc antibody IgG (lane 4), or 200-fold excess of unlabeled HSE/Qp oligonucleotide (lane 3) to conﬁrm the binding spec-
iﬁcity. C, Compared with wild HSE/Qp oligonucleotide probe (lanes 3 and 5), Qp probe with mutations at the HSE sequence could not form the shifted band (lane 4) or supershifted
band (lane 6) with heat shocked B95-8 cell extract. The density of Qp/HSF1 complex band in lane 3 decreased (lower band in lane 5) when supershifted band (upper band in lane 5)
appeared upon addition of HSF1 antibody. (D) ChIP analysis of HSE/Qp element from heat treated or unheated cells using antibody speciﬁc for HSF1 (lanes 3, 4) or rat IgG control
(lanes 1, 2). Input chromatins are presented in lanes 5 and 6. The primers speciﬁc for the EBV L1-TR promoter was used as negative control (lanes 7–10). HS+, heat shock treated.
HS–, without heat shock treatment. Compared with band 3, the intensity of band 4 was increased by 2.15-fold. The intensity of bands was estimated with the Quantity One 1-D
analysis software program (Bio-Rad).
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luciferase) was transiently transfected into HaCaT cells. As demon-
strated in Fig. 4, the mutant rendered the cells resistant to induction
by HSF1 overexpression (Fig. 4A) or heat shock (Fig. 4B). Taken to-
gether, the results from the EMSA and ChIP assays conﬁrmed that
the speciﬁc HSF1 binding element is located between −17 and +4
region of Qp, and thus we identiﬁed HSF1 as a new transcriptional
factor of EBNA1.
Discussion
To investigate the impact of the heat shock on EBV genes expres-
sion, the mRNA transcribed from the four viral promoter Cp, Wp, Fp,
Qp were analyzed by RT-PCR, respectively, in heat treated or
untreated B95-8 and human LCL cell lines. We observed that EBNA1
transcripts from Qp was upregulated by heat shock with a corre-
sponding increase in the protein level of EBNA1, while the Cp and
Fp-initiated transcripts was unchanged after heat treatment. Next,
to understand whether or not HSF1 is involved in heat-inducedEBNA1 expression, HSF1-speciﬁc RNA interference was performed
in heat-treated B95-8 cells and found to eliminate the heat induction
of EBNA1 mRNA expression. Computer-assisted identiﬁcation of the
putative HSE revealed a potential HSE rich in nGAAnnTGCnmotifs be-
tween the −17- and +4-nt region of Qp. The EMSA assays demon-
strated the −17/+4 segment had binding activity to HSF1. The ChIP
assay further indicated that HSF1 potentially associated with the puta-
tive HSE in vivo. These ﬁndings conﬁrmed that HSF1 upregulates
EBNA1 expression by binding to the EBNA1 promoter Qp in B95-8 cells.
Qp is highly active in EBV-positive malignancies, but has weak ac-
tivity and causes a low level of gene transcription in uncultured pe-
ripheral blood lymphocytes and group III latency (Tao et al., 1998;
Zetterberg et al., 1999). Cp has been considered as the major promot-
er used for the expression of EBNA1 transcripts in EBV transformed
lymphoblastoid cell line. Unexpectedly, the increased EBNA1 tran-
scripts was detected with the Q/U/K splice structure, but not
Y3/U/K-spliced forms of Cp/Wp-initiated mRNAs in B95-8 and
human LCL cells after heat shock treatment. Recent studies have
shown that Fp and Qp driven transcripts can be distinguished in
Table 1
Sequences and coordinates of oligonucleotides used in this study.
Applications and target transcript Oligo Sequence (5′→3′)a B95-8 genomic coordinates
RT-PCR
Cp initiated C1C2 (F) CATCTAAACCGACTGAAGAA 11470–11479/11626–11635
Wp initiated W0W1 (F) GTCCACACAAATCCTAG 14399–14410/14554–14558
Cp/Wp initiated W2 (R) CCCTGAAGGTGAACCGCTTA 14832–14813
EBNA1 Y3 (F) TGGCGTGTGACGTGGTGTAA 48397–48416
Q (F) GGATAGCGTGCGCTACCGGAT 62433–62453
F (F) ATATGGATCCGGAGGGGACCACTA 62249–62268
K (R) CATTTCCAGGTCCTGTACCT 107986–107967
EBNA2 Y2 (F) TGACAAGCTTGCGCCAATCTGTCTACATAG 47941–47960
Y3/P (R) ACTGGAATTCCCCCCATGTAACGCAAGATAG 48536–48516
BZLF1 exon 1 (F) TTCCACAGCCTGCACCAGTG 102719–102700
exon2/3 splice (R) GGCAGCAGCCACCTCACGGT 102330–102341/102426–102433
LMP1 Forward TCCTCCTCTTGGCGCTACTG 169383–169364
Reverse TCATCACTGTGTCGTTGTCC 168740–168759
GAPDH Forward ACCACAGTCCATGCCATCAC
Reverse TCCACCACCCTGTTGCTGTA
Real-time RT-PCR
EBNA1 Forward TCCTCTGGAGCCTGACCTGTGATCG 67563–67587
Reverse CATGATTCACACTTAAAGGAGACGG 67649–67636
GAPDH Forward ACA CCC ACT CCT CCA CCT TTG
Reverse CAT ACC AGG AAA TGA GCT TGA CAA
RNA interference of HSF1 Forward GAGAAAGAUCCCCCUGAUGdTdT
Reverse CAUCAGGGGGAUCUUUCUCdTdT
Luciferase construction
Qp (−219 to +58) Forward TCAGATCTTATAACGCAGGTCCTG 62203–62219
Reverse CGCAAGCTTTGTAAGGATAGCATG 62479–62464
mQp (−219 to +58) Forward GCAGATCTTATAACGCAGGTCCTG
Reverse 1 CTATTTTGTCTCGCAAAGCGTGGC
Reverse 2 GCCTTTTGAAGCCTATTTTGTCTCG
Reverse 3 ACGCTATCCCGCGCCTTTTGAAG
Reverse 4 ATCCGGTAGCGCACGCTATCCC
Reverse 5 GTATTACCCGCCATCCGGTAGCG
Reverse 6 TAAGGATAGCATGTATTACCCGCC
Reverse 7 CGCAAGCTTTGTAAGGATAGCATG
EMSA
Qp/HSE (−19 to +5) Qp probe Biotin-TGCGAAAACGAAAGTGCTTGAAAA 62403–62426
mQp/HSE (−19 to +5) mQp probe Biotin-TGCGAGACAAAATAGGCTTCAAAA 62403–62426
ChIP
Qp (−81/+53) Forward CTGAGGGAGTGTTCCACAGTAATG 62341–62365
Reverse GGATAGCATGTATTACCCGCCATC 62475–62451
LMP1-TR promoter Forward GTGACGAAGCAGCAGAC 169976–169993
(+124/−220) Reverse CCCTCATCACGGTCAC 170319–170303
a The underline indicates HSE inverted repeats (nnGAAnnTGCnn). The italicized bases indicate mutations to generate the mutated HSE probe.
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ply by using speciﬁc primers (Schaefer et al., 1996; Tsai et al., 1995).
We explored the further possibility that these Q/U/K-spliced wereFig. 4. Transcriptional induction of Qp activity by HSF1 overexpression and heat shock treatm
wild type Qp (Qp luciferase) activity in the HaCaT cell line, while the mutations of HSE sequ
normalized luciferase activity of vector was set as 1. The result was expressed as the mean o
ted. HS–, without heat shock treatment. HSF1(WT), human wild-type HSF1. HSF1(+), consarising from Fp since that circa 1 to 5% of B95.8 cells are lytically
infected (Zetterberg et al., 1999). However, The Fp driven EBNA1
transcripts (F/K-spliced) were detected in heated and unheated cellsent. HSF1 overexpression (A) and heat shock treatment (B) signiﬁcantly enhanced the
ence from the Qp (mQp luciferase) eliminated the induction of luciferase activity. The
f three independent experiments±S.D. *, Pb0.05 versus control. HS+, heat shock trea-
titutively active HSF1.
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screening of the heat treated B95-8 cells for evidence of BZLF1
mRNA, a much more sensitive indicator of lytic cycle entry than
Q/U/K-spliced transcripts, gave same results. We infer, therefore,
that the increased EBNA1 transcription is initiated from Qp that is ac-
tivated by heat shock treatment. The evidence from in vitro systems
would suggest that Qp and Cp/Wp function as mutually exclusive
promoters (Lear et al., 1992; Sample et al., 1991; Schaefer et al.,
1991), but such rules may not be necessary in the in vivo situation.
The report that Qp activity could be detected in infectious mononu-
cleosis mononuclear cells showed that Qp-initiated transcription oc-
curs in infected cells in which Cp/Wp is also active (Tierney et al.,
1994). Thus, we suggest that Qp might be active in latency III cells
under certain conditions such as heat shock.
As a TATA-less promoter that resembles housekeeping gene pro-
moters, Qp is hypomethylated in all situations in which it has been ex-
amined (Schaefer et al., 1997), then the quiescence of Qp may reﬂect
the lack of positive regulatory factors. Our study provides evidence
that the cellular response to the stress stimuli could be an inducer for
the Qp activity in B95-8 cells. The heat shock response is considered as
a defense against general protein damage and can be elicited by heat, in-
fection and inﬂammation, and pharmacological agents. EBV infection
might be a trigger to heat shock response. This was supported by the re-
ports which showed that peripheral blood B cells immortalized in vitro
by EBV express elevated levels of HSP70 and HSP90 (Cheung and
Dosch, 1993) and that EBV infection may increase expression of phos-
phorylated HSP27 in gastric cancer (Fukagawa et al., 2008; Schlager et
al., 1996). Schlager et al. (1996) measured early activation of Qp in
EBV-negative BL cells infected with EBNA2-deleted virus before the
upregulation of Cp activity. It is possible that viral infection triggered
heat shock response and then induced Qp activity, and then the induced
EBNA1 expression activated Cp activity. If so, Qp may play a role at the
early stage of viral infection. Although the alteration in the EBNA1
mRNA level by the heat shock treatment was modest in this study, it
might be crucial for the viral maintenance and gene expression in the
early stage of EBV infection.
Previous mass studies have shown that Qp is regulated by multi-
ple cellular and viral factors. A short sequence around the transcrip-
tion start site of Qp contains binding sites for multiple transcription
factors and provides a basis for combinatorial interactions between
different factors. The Qp HSF1-binding site (−17 to +4) described
in our work overlaps with the interferon-stimulated response ele-
ment (ISRE) (−18 to −4), two STAT-binding sites (−21 to −12
and−6 to +3) and RNA polymerase II binding site (+1). The inter-
action between STAT1 and HSF1 has been reported previously in HSP-
70 and HSP-90β gene promoters (Stephanou et al., 1999). Clearly, fur-
ther experiments are needed to verify the potential interaction of the
regulatory signals on the regulation of Qp.
In summary, we provided evidence in the present study that EBNA1
is a novel molecular target of HSF1 via interaction with an HSE within
the Q promoter region. EBNA1 is the only viral protein consistently
expressed in all malignancies associated with EBV and plays important
roles in the initiation of viral DNA replication, themitotic segregation of
the viral genomes and the transcriptional activation of other EBV laten-
cy proteins (Wu et al., 2002). As Qp is the key promoter in regulating
EBNA1 expression in EBV-associated tumors, ourﬁnding that the interac-
tion of HSF1 with Qp and corresponding increase in heat shock-induced
EBNA1 expression indicates that HSF1 may have a role in the develop-
ment of EBV-associated tumors.
Materials and methods
Primers, oligonucleotides, and probes
All oligonucleotides were synthesized by Invitrogen, Shanghai,
China. Table 1 shows the sequences of oligonucleotides used forluciferase construction, PCR site-directed mutagenesis, reverse tran-
scription-PCR, EMSA, ChIP and small interfering (si) RNA. Complemen-
tary oligonucleotides were synthesized and labeled by 5′ end ﬁlling
with biotin (Invitrogen, Shanghai, China) for the EMSA assay.
Cell lines
B95-8 is a marmoset B cell line transformed by EBV. LCLs is a EBV-
transformed human B-cell line (LCL) kindly provided by Dr Jiang Li (Li
et al., 2007). The spontaneously transformed human keratinocyte cell
line HaCaT was derived from normal human trunk skin. Cell lines
were maintained by our laboratory in RPMI 1640 plus 10% fetal bo-
vine serum (FBS) at 5% CO2 and 37 °C. For heat shock treatment, all
the cells utilized in this study were incubated for 1 h at 43 °C.
Plasmid construction
The QIAamp DNA Kit (Qiagen, Hilden, Germany) was used for DNA
extraction. A 294 bp fragment of the EBV Qp, from−219 to +58 rel-
ative to the transcriptional start site (coordinates 62203 to 62479 in
the B95-8 genome) was ampliﬁed from the genomic DNA of B95-
8 cells. PCR products were cloned into the pGEM-T easy vector
(Promega, Madison, WI) and subcloned into the Bgl II and Hind III
sites of the pGL3-basic (Promega) vector. For the mutated con-
struct (mQp), mutations were introduced into Qp plasmid using a
modiﬁcation of the overlap extension PCR method. A series of 3′
partially overlapping primers, which introduced base substitutions,
were used for the ampliﬁcation. The ﬁnal product was digested with
Bgl II and Hind III, gel-puriﬁed, and cloned into the Bgl II/Hind III sites of
pGL3-basic. Recombinants were conﬁrmed by enzymes digestion and
sequencing. The pcDNA3.1+ constructs encoding wild-type HSF1
(HSF1(WT)) and constitutively active HSF1 (HSF1(+)) were kindly
provided by Richard Voellmy (HSF Pharmaceuticals S.A., Switzerland)
(Xia et al., 1999).
Transfection and reporter assay
Twenty-four hours after HaCaT cells (10×104 cells/well) were
seeded into 24-well plates, the cells in each well were transfected
with 0.4 μg pGL3 reporter construct, 0.1 μg pcDNA3.1-HSF1 expres-
sion construct and 10 ng pRL-TK as internal control. Transfections
were carried out in three replicate wells using Lipofetamine™ 2000
(Invitrogen) as described in the manual. The cells were given fresh
medium after incubation for 6 h at 37 °C and harvested at 48 h post-
transfection. After incubation in fresh medium at 37 °C for 2 h, the
transfected cells were subjected to heat shock or not, and then were
harvested for the luciferase assay using the Dual Luciferase Reporter
Assay System (Promega) and a Sirius Luminometer V3.1 (Berthold
Detection Systems, Germany) according to the manufacturers' in-
structions. The experiment was performed independently at least
three times.
RT-PCR
Total RNA was isolated with TRIzol (Invitrogen, CA, USA) from
B95-8 or LCLs cells after exposure to heat shock or not at indicated re-
covery times. RT-PCR was performed using PrimeScript II 1st Strand
cDNA Synthesis Kit (Takara, Dalian, China). The primer sequences
are listed in Table 1. The ampliﬁcation conditions consisted of 32 cy-
cles of 30 s at 94 °C, 30 s at 55 °C, and 30 s at 72 °C for the EBNA1
and EBNA2 fragment, 34 cycles of 30 s at 94 °C, 30 s at 52 °C, and
30 s at 72 °C for other EBV transcripts fragment listed in Table 1 and
24 cycles for GAPDH. PCR products were analyzed by 1% agarose gel
electrophoresis and ethidium bromide staining.
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Total RNA from B95.8 cells was isolated with TRIzol reagent as
recommended by the manufacturer (Invitrogen, CA, USA). RNA
(2 μg) was reverse-transcribed in a total volume of 25 μl to obtain the
ﬁrst-strand cDNA using PrimeScript II 1st Strand cDNA Synthesis Kit
(Takara, Dalian, China). The primers for EBNA1 and GAPDH are listed
in Table 1. Real-time PCR was carried out in a total volume of 10 μl, in-
cluding 8 μl of TaqMan Power SYBR Green PCR Mix (Invitrogen), 0.5 μl
of each primer at 25 μM, and 1 μl of cDNA. The quantitative RT-PCR
was performed using Applied Biosystems 7900HT Fast Real-Time PCR
System. The thermal conditions of RT-PCR consisted of 40 cycles of
15 s at 95 °C and 60 s at 60 °C. Melt curve analyses were performed
for reactions using SYBR green. Quantiﬁcation of target gene expression
was normalized to GAPDH and expressed as fold change from control
groups using the comparative CT method.
Western blot analysis and antibodies
Cellular protein extractions were prepared by using M-PER
Mammalian Protein Extraction Reagent (Pierce, Rockford, IL) and a
Protease Inhibitor Cocktail (Sigma, Missouri, USA). Protein concen-
trations were determined by the BCA method (Pierce). For each
sample, 20 μg of protein (but at least 70 μg of cellular protein for
detecting EBNA1 from B95-8 cells) was loaded and separated by 10%
SDS-polyacrylamide gel and then transferred to a polyvinylideneﬂuoride
(PVDF) membrane (Roche). After blocking with 5% non-fat dry milk in
TBST, membranes were probed with the following antibodies: HSF1
Ab4 (NeoMarkers #RT-629-P1ABX), anti-EBNA1 (Santa Cruz, Europe)
and anti-GAPDH (Santa Cruz).
Transfection of siRNA
siRNA targeting the human HSF1 mRNA (GenBank accession no.
NM005526) was synthesized by Guangzhou Ribobio Company
(Guangzhou, China). Two complementary oligonucleotides were
annealed to generate double stranded DNAs. B95-8 cells, grown in
antibiotic-free RPMI 1640 supplemented with 10% FBS to be 30–50%
conﬂuent, were transfected with HSF1-speciﬁc siRNA or a control
(scrambled) siRNA using Lipofectamine™ 2000 transfection reagent
following the manufacturer's protocol (Invitrogen). The ﬁnal siRNA
concentration was 50 nM for each transfection. In all experiments,
cells underwent an identical second round of siRNA transfection 48 h
after the ﬁrst transfection. At 48 h after the last transfection, cells
were collected for analysis. For heat shock treatment, cells were heat
shocked at 10 h after the last transfection and then incubated at 37 °C
for 20 h.
Electrophoretic mobility shift assay
B95-8 cellswere heat shocked and then harvested in cold phosphate-
buffered saline (PBS) to extract nuclear proteins. Nuclear extracts were
prepared according to the NucBuster™ Protein Extraction Kit (Novagen
71183–3) protocol but without adding DTT. The oligonucleotide probes
were synthesized and labeled by 5′ end ﬁlling with biotin (Invitrogen).
The sequences of the oligonucleotides used in EMSA are shown in
Table 1. EMSA was performed using the LightShift® Chemiluminescent
EMSA Kit according to the manufacturer's protocol (Pierce). Each bind-
ing mixture (10 μl) contained 2 μl of nuclear extract, 1 μg of poly
(dI/dC), 1 μl 10× binding buffer, 1 μl 50% glycerol and 200 fmol of labeled
oligonucleotide probe, with or without 200 fold excess cold competitor
double-stranded oligonucleotides. The samples were incubated at
room temperature for 20 min. For the supershift assay, nuclear ex-
tracts were incubated with 2 μl anti-HSF1 monoclonal antibody
(NeoMarkers #RT-629-P1ABX) for 30 min at room temperature be-
fore the addition of labeled probe. The DNA-protein complexeswere then electrophoretically resolved on 6.5% nondenaturing poly-
acrylamide gels. Transfer was performed at 380 mA for 40 min. The
transferred DNA was cross-linked to the membrane and detected
by chemiluminescence and exposure to X-ray ﬁlm.
Chromatin immunoprecipitation assay
The ChIP assaywas performed using the EZ-Magna ChIP G Chromatin
immunoprecipitation kit (Millipore Corporation, Billerica, MA) with
somemodiﬁcations. B95-8 cellswere heat shocked or not followed by in-
cubating at 37 °C for 2 or 3 h and thenwere cross-linked in 1% formalde-
hyde. After 10 min, 0.125 M glycine was added to stop the cross-linking
for 5 min. The cells were washed twice in ice-cold PBS and lysed in cell
lysis buffer with protease inhibitor cocktail for 15 min on ice. The nuclei
were lysed in nuclear lysis buffer for 10 min on ice. The lysates were
sonicated on wet ice for six 12-s bursts using a Misonix Microson™
XL2000 Ultrasonic Processor (USA) with output setting at 8. The
sheared chromatin was diluted 10-fold using ChIP dilution buffer
and precleared for 2 h at 4 °C using 20 μl protein G magnetic beads.
Immunoprecipitation was carried out at 4 °C overnight using a rat
anti-HSF-1 antibody (NeoMarkers) or a control rat IgG. The immune
complexes were incubated with magnetic beads for 2 h at 4 °C. The
bead-antibody-protein-DNA complexes were immunoprecipitated
and washed, and the DNA is puriﬁed after reversal of protein-DNA
cross-links. Quantitation of the DNA from the Q promoter regions
was determined by PCR using gene-speciﬁc primers as described in
Table 1. PCR was performed on either DNA immunoprecipitated
with anti-HSF-1 or the rat control IgG, or on chromatin input that
had not been immunoprecipitated. The primers speciﬁc for the
LMP1-TR promoter were used as a negative control, and the total
input chromatin from antibody-free samples as the positive control.
The PCR conditions were 95 °C for 30 s, 33 cycles of 95 °C for 30 s,
50 °C for 30 s, and 72 °C for 30 s, followed by 72 °C for 7 min to com-
plete primer extension.
Statistics
Data are presented as the mean±SD. The differences were
assessed by analysis of variance with double-sided t-test for compar-
isons within multiple groups. Statistical signiﬁcance was deﬁned as
Pb0.05.
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